Sharp recovery from prior-day plunge drives AIFF premarket gain on low-volume rebound.
Firefly Neuroscience Inc. (AIFF) closed at $1.53 on March 20 after plunging 29.82% on heavy volume, following a period of elevated volatility tied to earlier March announcements around ADHD brain-wave biomarkers, commercial expansion, and foundation model progress using NVIDIA GPUs. On March 23 premarket, the stock rebounded approximately 25.49% to the $1.90–1.96 area, with reports noting gains around 24–27% early in the session. Multiple financial outlets explicitly stated there was no new company announcement, press release, earnings update, regulatory filing, or other fundamental catalyst on March 23 or over the immediate weekend. The move occurred in thin premarket liquidity typical for this micro-cap name, which has shown repeated sharp swings (including 40%+ moves earlier in March). Analysts and market commentary described it as a technical rebound, possible short covering, retail momentum, or algorithmic activity rather than any fresh news. The company’s most recent verifiable events were the March 13 ADHD biomarker announcement and March 4 commercial growth update, but these are too distant to serve as a direct trigger for today’s session.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.